Improved stability of KGF by conjugation with gold nanoparticles for diabetic wound therapy
Abstract
Aim: Diabetic wound healing is seriously interrupted, and administration of KGF for wound treatment is restricted by its inherent instability. We aim to develop an ideal way toward KGF stabilization, thus improving diabetic wound healing. Materials & methods: We conjugated KGF with gold nanoparticles (GNPs) and determined the stability and binding affinity. Biological effects of conjugates (KGF-GNPs) were evaluated in vitro and in an animal model. Results: KGF-GNPs revealed high stability under hostile circumstances because of the preserved secondary structure and possessed elevated binding affinity to KGF receptor. Moreover, application of KGF-GNPs contributed to accelerated wound recovery in diabetic rats, including re-epithelialization and contraction. Conclusion: KGF-GNPs were promising for future clinical application for diabetic wound therapy.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. Simulating inflammation in a wound microenvironment using a dermal wound-on-a-chip model. Adv. Healthc. Mater. 8(1), 1–12 (2019).
- 2. . Diabetic foot ulcers and their recurrence. N. Engl. J. Med. 376(24), 2367–2375 (2017).
- 3. Identification of specific miRNAs in neutrophils of Type 2 diabetic mice: overexpression of miRNA-129-2-3p accelerates diabetic wound healing. Diabetes 68(3), 617–630 (2019).
- 4. Wound healing can be improved by (-)-epigallocatechin gallate through targeting Notch in streptozotocin-induced diabetic mice. FASEB J. 33(1), 953–964 (2019).
- 5. Validation of matrix metalloproteinase-9 (MMP-9) as a novel target for treatment of diabetic foot ulcers in humans and discovery of a potent and selective small-molecule MMP-9 inhibitor that accelerates healing. J. Med. Chem. 61(19), 8825–8837 (2018).
- 6. . Non-healing foot ulcers in diabetic patients: general and local interfering conditions and management options with advanced wound dressings. J. Wound Care 24(4), 35–42 (2015).
- 7. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 266(5186), 819–822 (1994). •• Highlights the significant role of KGF during wound repair.
- 8. . Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl Acad. Sci. USA 89(15), 6896 (1992).
- 9. Requirement of G alpha i1/3-Gab1 signaling complex for keratinocyte growth factor-induced PI3K-AKT-mTORC1 activation. J. Invest. Dermatol. 135(1), 181–191 (2015).
- 10. . Co-delivery of a growth factor and a tissue-protective molecule using elastin biopolymers accelerates wound healing in diabetic mice. Biomaterials 141, 149–160 (2017).
- 11. . Keratinocyte growth factor induces granulation tissue in ischemic dermal wounds. Importance of epithelial–mesenchymal cell interactions. Arch. Surg-Chicago 131(6), 660–666 (1996).
- 12. Keratinocyte growth factor modified messenger RNA accelerating cell proliferation and migration of keratinocytes. Nucl. Acid Ther. 28(6), 335–347 (2018).
- 13. . Topical treatment with anti-oxidants and Au nanoparticles promote healing of diabetic wound through receptor for advance glycation end-products. Eur. J. Pharm. Sci. 47(5), 875 (2012). • An example of topical application of gold nanoparticles in cutaneous diabetic wounds.
- 14. . Noninvasive photothermal cancer therapy nanoplatforms via integrating nanomaterials and functional polymers. Biomaterials Science 5(2), 190–210 (2017).
- 15. . Gold nanoparticles in cancer treatment. Mol. Pharm. 16(1), 1–23 (2019).
- 16. . Emerging advances in nanomedicine with engineered gold nanostructures. Nanoscale 6(5), 2502–2530 (2014). • Review article on the progress made in medical application with gold nanostructures.
- 17. Topical application of keratinocyte growth factor conjugated gold nanoparticles accelerate wound healing. Nanomedicine 14(5), 1619–1628 (2018). •• Description of synthesis and modification of the used functionalized gold nanoparticles in the current study as well as their application on normal wounds.
- 18. . Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc. 1(6), 2876–2890 (2006).
- 19. Nanostructured mineral coatings stabilize proteins for therapeutic delivery. Adv. Mater. 29(33), 1701255 (2017). • Work illustrating a method to stabilize proteins and proposed mechanism.
- 20. . Virus-mediated knockdown of Nav1.3 in dorsal root ganglia of STZ-induced diabetic rats alleviates tactile allodynia. Mol. Med. 21(1), 544–552 (2014).
- 21. . Lack of FGF-7 further delays cutaneous wound healing in diabetic mice. Plast. Reconstr. Surg. 128(6), 673e–684e (2011).
- 22. Flexible pH-sensing hydrogel fibers for epidermal applications. Adv. Healthc. Mater. 5(6), 711–719 (2016).
- 23. . Synergistic effects of hyaluronate – epidermal growth factor conjugate patch on chronic wound healing. Biomater. Sci. 6(5), 1020–1030 (2018).
- 24. . Calcium-sensing receptor regulates epidermal intracellular Ca2+ signaling and re-epithelialization after wounding. J. Invest. Dermatol. 139(4), 919–929 (2019).
- 25. . Dynamics and self-assembly of bio-functionalized gold nanoparticles in solution: reactive molecular dynamics simulations. Nano Res. 11(4), 1757–1767 (2018).
- 26. . Polymerizable ligands as stabilizers for nanoparticles. Part. Part. Syst. Charact. 32(4), 417–428 (2015).
- 27. . Preparation of ordered colloid monolayers by electrophoretic deposition. Langmuir 9(12), 3408–3413 (1993).
- 28. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J. Am. Chem. Soc. 132(13), 4678–4684 (2010).
- 29. . Noncovalent PEGylation by polyanion complexation as a means to stabilize keratinocyte growth factor-2 (KGF-2). Biomacromolecules 12(11), 3880–3894 (2011).
- 30. . A polymer scaffold for protein oligomerization. J. Am. Chem. Soc. 126(6), 1608–1609 (2004).
- 31. . A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor. Nat. Chem. 5(3), 221–227 (2013).
- 32. . Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat. Rev. Drug Discov. 13(9), 655–672 (2014).
- 33. . Circular dichroism spectroscopy of membrane proteins. Chem. Soc. Rev. 45(18), 4859–4872 (2016).
- 34. Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy. Proc. Natl Acad. Sci. USA 112(24), E3095–E3103 (2015).
- 35. . Stabilization of proteins by nanoencapsulation in sugar-glass for tissue engineering and drug delivery applications. Adv. Mater. 23(42), 4861–4867 (2011).
- 36. . Nanoparticulate systems for growth factor delivery. Pharm. Res. 26(7), 1561 (2009).
- 37. Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J. Exp. Med. 178(3), 865 (1993).
- 38. . Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am. J. Pathol. 164(6), 2055 (2004).
- 39. . Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast. Exp. Cell Res. 257(1), 180–189 (2000).
- 40. . Chitosan-hyaluronic acid/VEGF loaded fibrin nanoparticles composite sponges for enhancing angiogenesis in wounds. Colloid Surf. B-Biointerfaces 127, 105–113 (2015).